Share-based Payment Arrangement, Expense of Hoth Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Hoth Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Hoth Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,134,575, a 300% increase year-over-year.
  • Hoth Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,410,570, a 74% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $804,277, a 272% increase from 2023.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $216,428, a 65% decline from 2022.
  • Hoth Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $620,798, a 53% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Hoth Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,410,570 $1,134,575 +$851,243 +300% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $559,327 $55,525 +$48,471 +687% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $510,856 $219,929 -$293,421 -57% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $804,277 $541 -$5,244 -91% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $809,521 $283,332 +$93,067 +49% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $716,454 $7,054 -$2,694 -28% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $719,148 $513,350 +$502,720 +4729% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $216,428 $5,785 -$9,683 -63% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $226,111 $190,265 +$177,911 +1440% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $48,200 $9,748 -$5,790 -37% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $53,990 $10,630 -$566,808 -98% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $620,798 $15,468 -$110,523 -88% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $731,321 $12,354 -$28,076 -69% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $759,397 $15,538 -$14,824 -49% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $774,221 $577,438 -$548,600 -49% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,322,821 $125,991 +$173,759 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $1,149,062 $40,430 -$620,702 -94% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $1,769,764 $30,362 +$14,282 +89% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $1,755,482 $1,126,038 +$1,017,736 +940% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $737,746 $47,768 -$2,046,152 -102% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $2,783,898 $661,132 +$454,372 +220% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $2,329,526 $16,080 -$71,286 -82% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $2,400,812 $108,302 -$94,407 -47% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,495,219 $1,998,384 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $206,760 +$201,171 +3599% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $87,366 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $202,709 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q3 2018 $5,589 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3

Hoth Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $804,277 +$587,849 +272% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $216,428 -$404,370 -65% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $620,798 -$702,023 -53% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $1,322,821 +$585,075 +79% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $737,746 -$1,757,473 -70% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $2,495,219 +$2,352,166 +1644% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
2018 $143,053 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.